Cathelicidin rCRAMP stimulates rat mast cells to generate cysteinyl leukotrienes, synthesize TNF and migrate: Involvement of PLC/A2, PI3K and MAPK signaling pathways

International Immunology

Volumn 26, Issue 11, 2014, Pages 637-646

  Babolewska, Edyta ^a   Pietrzak, Anna ^a   Brzezińska Błaszczyk, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Anti microbial peptide; Host defense; Inflammation; Innate immunity; Mast cell functioning

Indexed keywords

CATHELICIDIN; CATHELICIDIN RELATED ANTI MICROBIAL PEPTIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDOLEUKOTRIENE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; POLYPEPTIDE ANTIBIOTIC AGENT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CATHELICIDIN ANTIMICROBIAL PEPTIDE; CYSTEINE; CYSTEINYL-LEUKOTRIENE; CYTOKINE; LEUKOTRIENE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; MAST CELL; NONHUMAN; PROTEIN SYNTHESIS; RAT; ANIMAL; BIOSYNTHESIS; CELL MOTION; DEGRANULATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION; HISTAMINE RELEASE; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CATHELICIDINS; CELL DEGRANULATION; CELL MOVEMENT; CYSTEINE; CYTOKINES; FEMALE; GENE EXPRESSION; HISTAMINE RELEASE; LEUKOTRIENES; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOINOSITIDE PHOSPHOLIPASE C; PHOSPHORYLATION; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS;

EID: 84911422228     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxu069     Document Type: Article

References (47)

1. Weller, C. L., Collington, S. J., Williams, T. and Lamb, J. R. 2011. Mast cells in health and disease. Clin. Sci. (Lond). 120:473.
2. Rao, K. N. and Brown, M. A. 2008. Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann. N. Y. Acad. Sci. 1143:83.
3. Tsai, M., Grimbaldeston, M. and Galli, S. J. 2011. Mast cells and immunoregulation/immunomodulation. Adv. Exp. Med. Biol. 716:186.
4. Abraham, S. N. and St John, A. L. 2010. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10:440.
5. Urb, M. and Sheppard, D. C. 2012. The role of mast cells in the defence against pathogens. PLoS Pathog. 8:e1002619.
6. Matsuguchi, T. 2012. Mast cells as critical effectors of host immune defense against Gram-negative bacteria. Curr. Med. Chem. 19:1432.
7. Felaco, P., Toniato, E., Castellani, M. L. et al. 2009. Infections and mast cells. J. Biol. Regul. Homeost. Agents 23:231.
8. Brzezińska-Blaszczyk, E. and Wierzbicki, M. 2010. Mast cell Tolllike receptors (TLRs). Postepy. Hig. Med. Dosw. 64:11.
9. Arock, M., Ross, E., Lai-Kuen, R., Averlant, G., Gao, Z. and Abraham, S. N. 1998. Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria. Infect. Immun. 66:6030.
10. Lima, H. G., Pinke, K. H., Gardizani, T. P. et al. 2013. Mast cells act as phagocytes against the periodontopathogen Aggregatibacter actinomycetemcomitans. J. Periodontol. 84:265.
11. von Köckritz-Blickwede, M., Goldmann, O., Thulin, P. et al. 2008. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 111:3070.
12. Frandji, P., Oskéritzian, C., Cacaraci, F. et al. 1993. Antigendependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151:6318.
13. Nakano, N., Nishiyama, C., Yagita, H., Koyanagi, A., Ogawa, H. and Okumura, K. 2011. Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells. J. Biol. Chem. 286:12042.
14. Malaviya, R., Twesten, N. J., Ross, E. A., Abraham, S. N. and Pfeifer, J. D. 1996. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156:1490.
15. Shelburne, C. P. and Abraham, S. N. 2011. The mast cell in innate and adaptive immunity. Adv. Exp. Med. Biol. 716:162.
16. Choi, K. Y., Chow, L. N. and Mookherjee, N. 2012. Cationic host defence peptides: multifaceted role in immune modulation and inflammation. J. Innate Immun. 4:361.
17. Kosciuczuk, E. M., Lisowski, P., Jarczak, J. et al. 2012. Cathelicidins: family of antimicrobial peptides. A review. Mol. Biol. Rep. 39:10957.
18. Zanetti, M. 2005. The role of cathelicidins in the innate host defenses of mammals. Curr. Issues Mol. Biol. 7:179.
19. Di Nardo, A., Vitiello, A. and Gallo, R. L. 2003. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170:2274.
20. Wang, Z., Lai, Y., Bernard, J. J. et al. 2012. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides. J. Immunol. 188:345.
21. Wang, Z., MacLeod, D. T. and Di Nardo, A. 2012. Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses. J. Immunol. 189:1551.
22. Di Nardo, A., Yamasaki, K., Dorschner, R. A., Lai, Y. and Gallo, R. L. 2008. Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin. J. Immunol. 180:7565.
23. Murray, P. J. 2006. STAT3-mediated anti-inflammatory signalling. Biochem. Soc. Trans. 34(Pt 6):1028.
24. Juremalm, M., Olsson, N. and Nilsson, G. 2002. Selective CCL5/ RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem. Biophys. Res. Commun. 297:480.
25. Yoshioka, M., Fukuishi, N., Kubo, Y. et al. 2008. Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Biol. Pharm. Bull. 31:212.
26. Subramanian, H., Gupta, K., Guo, Q., Price, R. and Ali, H. 2011. Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization. J. Biol. Chem. 286:44739.
27. Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H. and Nagaoka, I. 2001. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31:1066.
28. Schiemann, F., Brandt, E., Gross, R. et al. 2009. The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: counter-regulation by CXCL4. J. Immunol. 183:2223.
29. Chen, X., Niyonsaba, F., Ushio, H. et al. 2006. Human cathelicidin LL-37 increases vascular permeability in the skin via mast cell activation, and phosphorylates MAP kinases p38 and ERK in mast cells. J. Dermatol. Sci. 43:63.
30. Niyonsaba, F., Ushio, H., Hara, M. et al. 2010. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J. Immunol. 184:3526.
31. Niyonsaba, F., Iwabuchi, K., Someya, A. et al. 2002. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106:20.
32. Ryan, J. J., Kashyap, M., Bailey, D. et al. 2007. Mast cell homeostasis: a fundamental aspect of allergic disease. Crit. Rev. Immunol. 27:15.
33. Shelburne, C. P. and Ryan, J. J. 2001. The role of Th2 cytokines in mast cell homeostasis. Immunol. Rev. 179:82.
34. Pietrzak, A., Misiak-Tłoczek, A. and Brzezińska-Blaszczyk, E. 2009. Interleukin (IL)-10 inhibits RANTES-, tumour necrosis factor (TNF)- and nerve growth factor (NGF)-induced mast cell migratory response but is not a mast cell chemoattractant. Immunol. Lett. 123:46.
35. Jeng, L., Yamshchikov, A. V., Judd, S. E. et al. 2009. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J. Transl. Med. 7:28.
36. Starner, T. D., Agerberth, B., Gudmundsson, G. H. and McCray, P. B. Jr. 2005. Expression and activity of beta-defensins and LL-37 in the developing human lung. J. Immunol. 174:1608.
37. Mandic Havelka, A., Yektaei-Karin, E., Hultenby, K. et al. 2010. Maternal plasma level of antimicrobial peptide LL37 is a major determinant factor of neonatal plasma LL37 level. Acta Paediatr. 99:836.
38. Xiao, W., Hsu, Y. P., Ishizaka, A., Kirikae, T. and Moss, R. B. 2005. Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. Chest 128:2316.
39. Chen, C. I., Schaller-Bals, S., Paul, K. P., Wahn, U. and Bals, R. 2009. Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J. Cyst. Fibros. 3:45.
40. Zhang, Z., Cherryholmes, G., Chang, F., Rose, D. M., Schraufstatter, I. and Shively, J. E. 2009. Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils. Eur. J. Immunol. 39:3181.
41. Yang, D., Chen, Q., Schmidt, A. P. et al. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192:1069.
42. Nagaoka, I., Tamura, H. and Hirata, M. 2006. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J. Immunol. 176:3044.
43. Girnita, A., Zheng, H., Grönberg, A., Girnita, L. and Ståhle, M. 2012. Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor. Oncogene 31:352.
44. Tokumaru, S., Sayama, K., Shirakata, Y. et al. 2005. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J. Immunol. 175:4662.
45. Tjabringa, G. S., Aarbiou, J., Ninaber, D. K. et al. 2003. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171:6690.
46. Elssner, A., Duncan, M., Gavrilin, M. and Wewers, M. D. 2004. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 172:4987.
47. Montreekachon, P., Chotjumlong, P., Bolscher, J. G., Nazmi, K., Reutrakul, V. and Krisanaprakornkit, S. 2011. Involvement of P2X(7) purinergic receptor and MEK1/2 in interleukin-8 up-regulation by LL-37 in human gingival fibroblasts. J. Periodontal Res. 46:327.